AI Medical Solutions provides AI-powered ophthalmology platforms such as OphtAI, Altris, and EyeLib that detect over 70 retinal pathologies—including diabetic retinopathy, glaucoma, and age‑related macular degeneration—in seconds, enabling early referral and treatment. The solutions are offered to optical shops, private health centers, and public health systems on a SaaS or device‑as‑a‑service model, generating revenue through subscription fees and equipment leasing.
Funding
Funding not disclosed
Founders
Product
Problem
The healthcare system faces a shortage of ophthalmology specialists, leading to delayed diagnoses and treatment for prevalent ocular conditions. This scarcity limits access to timely visual care, increasing the risk of preventable vision loss.
Solution
AI Medical Solutions provides an AI-powered platform designed to enhance early detection and management of ocular diseases. Our technology integrates with existing healthcare workflows to streamline the diagnostic process, enabling faster identification and referral of patients with conditions like diabetic retinopathy, glaucoma, and age-related macular degeneration. By leveraging advanced AI algorithms, we aim to expand the capacity of eye care services and reduce the incidence of avoidable vision impairment.
Target Audience
Our primary customers are optical retailers, private healthcare providers, and public health organizations seeking to improve the efficiency and accessibility of their ophthalmological services.
Features
- OphtAI: AI software for rapid, automated detection of key retinal pathologies including diabetic retinopathy, glaucoma, and AMD.
- Altris AI: AI platform for interpreting OCT scans, identifying over 70 retinal pathologies and biomarkers for enhanced diagnostic accuracy.
- EyeLib™ by Mikajaki: An integrated ophthalmic diagnostic station combining AI, robotics, and virtual agents for comprehensive eye exams.
- SmartVision™ Diagnostic Report: Generates a complete ophthalmological diagnostic report with prescription and surgical planning in approximately 6 minutes.
- Multi-modal diagnostic capabilities within EyeLib™, including anterior and posterior OCT, ocular biometry, wavefront aberrometry, and tonometry.
- AI-driven glaucoma risk assessment and quantitative biomarker analysis for longitudinal disease monitoring.
- Scalable deployment options for optical shops, private health centers, and public healthcare systems.